How care coordination benefited Jake's diabetes management

July 10, 2023

New Care Coordination Support Service funded by the SEMPHN helped Jake find a local GP and manage his diabetes in a new state.

Moving interstate to start a new job is a big thing to do. For Jake, it meant leaving behind friends and family and starting again in Melbourne’s south east. At first, he focused on work and joining a local soccer club.

With the move and the new job, Jake hadn’t found himself a new doctor yet.

Jake lives with diabetes and bipolar disorder. He had a few nights where he didn’t quite feel right and ended up at the local hospital. Jake was referred to Silverchain’s new free care coordination support service which helps people living in the Frankston and Greater Dandenong areas to take a proactive approach to managing their health including finding a local GP.

“Silverchain taught me that there is a lot I can do to take better care of myself. They found services where I could get appointments after work. I now have a mental health plan in place and have contacted my local diabetes service. I now know where to get help if I need it,” Jake said.

The new Care Coordination Support Service funded by the South Eastern Melbourne PHN helps to support eligible people who need a little extra help with taking care of themselves. By working closely with local GPs and pharmacies, we are helping to improve health outcomes for vulnerable people, reduce pressure on local hospitals, and empower people to take control of their health.

To find out more about our South Eastern Melbourne Care Coordination Support Service, visit www.silverchain.org.au/refer-to-us/victoria.

To make a referral please contact 1300 300 122 OR email screferrals@silverchain.org.au


Image supplied by Silverchain Group.

Latest news

September 13, 2026
South Eastern Melbourne PHN has launched the Clinical and Referral Guidance Hub (the Hub), a new platform providing primary care professionals in south east Melbourne with centralised access to local referral information and clinical guidance.
September 10, 2026
Sublocade® (long acting injectable buprenorphine) will be discontinued in Australia after 31 December 2026. The decision is not related to safety, quality or efficacy concerns and people currently receiving Sublocade® should continue their treatment as prescribed.
September 2, 2026
Thursday 10 September is World Suicide Prevention Day, a global day to raise awareness of suicide prevention and encourage open, compassionate conversations about suicide.